Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker.

Abstract

Azelnidipine (Calblock) is a newly developed dihydropyridine-type calcium antagonist for the treatment of hypertension. In hypertensive animals, a single oral administration of azelnidipine caused a slowly developed and long-lasting hypotensive effect with a little reflex tachycardia. The extent of tachycardia was less with azelnidipine than with other… (More)
DOI: 10.1254/fpj.122.539

Topics

Cite this paper

@article{Sada2003PharmacologicalPA, title={Pharmacological profiles and clinical effects of azelnidipine, a long-acting calcium channel blocker.}, author={Toshio Sada and Hironobu Saito}, journal={Nihon yakurigaku zasshi. Folia pharmacologica Japonica}, year={2003}, volume={122 6}, pages={539-47} }